Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment

Javad Sharifi‐Rad(Universidad del Azuay), Cristina Quispe(Arturo Prat University), Monica Butnariu(Univesity of Life Science "King Mihai I" from Timisoara), Lia Sanda Rotariu(Univesity of Life Science "King Mihai I" from Timisoara), Oksana Sytar(Taras Shevchenko National University of Kyiv), Simona Sestito(University of Pisa), Simona Rapposelli(University of Pisa), Muhammad Akram, Mehwish Iqbal(Dow University of Health Sciences), Akash Krishna(Manipal Academy of Higher Education), N. V. Anil Kumar(Manipal Academy of Higher Education), Susana S. Braga(Rede de Química e Tecnologia), Susana M. Cardoso(Rede de Química e Tecnologia), Karolina Jafernik(Jagiellonian University), Halina Ekiert(Jagiellonian University), Natália Martins(Universidade do Porto), Agnieszka Szopa(Jagiellonian University), Marcelo Villagrán(Universidad Católica de la Santísima Concepción), Lorena Mardones(Universidad Católica de la Santísima Concepción), Miquel Martorell(University of Concepción), Anca Oana Docea(University of Medicine and Pharmacy of Craiova), Daniela Călina(University of Medicine and Pharmacy of Craiova)
Cancer Cell International
June 24, 2021
Cited by 280Open Access
Full Text

Abstract

The study describes the current state of knowledge on nanotechnology and its utilization in medicine. The focus in this manuscript was on the properties, usage safety, and potentially valuable applications of chitosan-based nanomaterials. Chitosan nanoparticles have high importance in nanomedicine, biomedical engineering, discovery and development of new drugs. The manuscript reviewed the new studies regarding the use of chitosan-based nanoparticles for creating new release systems with improved bioavailability, increased specificity and sensitivity, and reduced pharmacological toxicity of drugs. Nowadays, effective cancer treatment is a global problem, and recent advances in nanomedicine are of great importance. Special attention was put on the application of chitosan nanoparticles in developing new system for anticancer drug delivery. Pre-clinical and clinical studies support the use of chitosan-based nanoparticles in nanomedicine. This manuscript overviews the last progresses regarding the utilization, stability, and bioavailability of drug nanoencapsulation with chitosan and their safety.


Related Papers

No related papers found

Powered by citation graph analysis